Matt Mandeville
Applications & Business Development BrainXell, Inc.
Seminars
Wednesday 15th April 2026
Advancing Drug Discovery with Human iPSC Neuroimmunology Models
12:00 pm
- BrainXell is a leading provider of hiPSC-derived neurons and glia, working with over 75% of the world’s largest pharmaceutical companies
- Review our comprehensive off-the-shelf portfolio, highlighting microglia and region-specific cortical/spinal astrocytes, as well as disease models and isogenic controls
- Robust, scalable manufacturing processes generate billions of cells, and flexible custom workflows deliver the same high-quality cell types from any customer-supplied iPSC line
- Assay services integrate functional and molecular readouts to support target validation, drug screening, disease modeling and accelerated discovery through direct scientific collaboration
